These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11898934)

  • 1. Ethics and industry-sponsored research.
    Pater JL; Parulekar W; O'Callagham C; Shepherd L; Eisenhouer E; Seymour L; Tu D; Ding K
    CMAJ; 2002 Mar; 166(5):581-2. PubMed ID: 11898934
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethics and industry-sponsored research.
    Kuebler C; Nimmo WS; von R; Gillings D; Morgan AT; Kendle C; Covington PS
    CMAJ; 2002 Mar; 166(5):579-80; author reply 582. PubMed ID: 11898930
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethics and industry-sponsored research.
    Miettinen OS
    CMAJ; 2002 Mar; 166(5):580-1; author reply 582. PubMed ID: 11898932
    [No Abstract]   [Full Text] [Related]  

  • 4. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine.
    Finkel AG
    Headache; 2006; 46(7):1181-5. PubMed ID: 16866722
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethics and industry-sponsored research.
    Koehler B
    CMAJ; 2002 Mar; 166(5):581; author reply 582. PubMed ID: 11898935
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethics and industry-sponsored research.
    Loschiavo SR
    CMAJ; 2002 Mar; 166(5):579; author reply 582. PubMed ID: 11898931
    [No Abstract]   [Full Text] [Related]  

  • 7. To protect those who serve.
    Miller FG
    N Engl J Med; 2001 Mar; 344(13):1018-9. PubMed ID: 11280318
    [No Abstract]   [Full Text] [Related]  

  • 8. Policy of the American Society of Gene Therapy on financial conflict ofinterest in clinical research.
    Woo SL
    Mol Ther; 2000 May; 1(5 Pt 1):383-4. PubMed ID: 10979736
    [No Abstract]   [Full Text] [Related]  

  • 9. CMA guidelines on MD-drug industry relations part of international trend.
    Williams JR
    CMAJ; 1992 Feb; 146(3):386-8. PubMed ID: 11654902
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary: Conflict of interest policies: an opportunity for the medical profession to take the lead.
    Lo B
    Acad Med; 2010 Jan; 85(1):9-11. PubMed ID: 20042812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bias and sponsored research.
    Kaufman SR
    Ophthalmology; 2008 Feb; 115(2):412-3; author reply 413. PubMed ID: 18243910
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethics and industry-sponsored research.
    Holmer AF
    CMAJ; 2002 Mar; 166(5):580; author reply 582. PubMed ID: 11898933
    [No Abstract]   [Full Text] [Related]  

  • 13. Unethical business practices in U.S. health care alarm physician leaders.
    Weber DO
    Physician Exec; 2005; 31(2):6-13. PubMed ID: 15844791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pharmaceutical companies in sponsored research.
    Novack GD
    Ophthalmology; 2007 Jun; 114(6):1037-8. PubMed ID: 17544773
    [No Abstract]   [Full Text] [Related]  

  • 15. Conflicts of interest with the health industry.
    Dubois MY
    Pain Med; 2006; 7(5):463-5. PubMed ID: 17014609
    [No Abstract]   [Full Text] [Related]  

  • 16. Physicians and the pharmaceutical industry (update 2001).
    Canadian Medical Association
    CMAJ; 2001 May; 164(9):1339-44. PubMed ID: 11341156
    [No Abstract]   [Full Text] [Related]  

  • 17. Philanthropy, ethics, and leadership in academic psychiatry.
    Roberts LW; Coverdale J; Louie AK
    Acad Psychiatry; 2006; 30(4):269-72. PubMed ID: 16908601
    [No Abstract]   [Full Text] [Related]  

  • 18. Physicians and the pharmaceutical industry.
    Canadian Medical Association
    CMAJ; 1992 Feb; 146(3):388A-C. PubMed ID: 11654903
    [No Abstract]   [Full Text] [Related]  

  • 19. Conflicts of interest at the industrial/academic interface.
    Phillipson EA
    Can J Clin Pharmacol; 2001; 8(1):7-8. PubMed ID: 11283755
    [No Abstract]   [Full Text] [Related]  

  • 20. Two cheers for the CMA's new guidelines on drug company-MD relations The CMA's MD-drug industry guidelines offer advice, nothing more.
    Rapp MS; Woollard R
    CMAJ; 1991 Dec; 145(11):1497-9. PubMed ID: 11649303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.